ClinicalTrials.Veeva

Menu

Infectious Mediastinitis Among the Strasbourg Universitary Hospital (MEDIASTINITIS)

U

University Hospital, Strasbourg, France

Status

Unknown

Conditions

Mediastinitis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Mediastinitis are rare but serious infections, with mortality rates varying from 6 to 30% according to the literature. They are essentially linked to surgical management (cardio-thoracic in particular), but some forms can be spontaneous, after extension of an ENT infectious focus, for example.

Despite their seriousness, there is no strong recommendations to define their management, especially concerning antibiotic therapy and its duration.

The aim of this research is to make a descriptive analysis of the cases of mediastinitis at HUS in recent years, and to study the therapeutic strategy used

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Major subject (≥18 years old)
  • Subject diagnosed with mediastinitis between 01/01/2010 and 31/12/2020
  • Subject not having expressed his opposition, after information, to the reuse of his data for the purposes of this research.

Exclusion criteria

  • Subject having expressed opposition to participate in the study
  • Subject under guardianship, curatorship or safeguard of justice

Trial contacts and locations

1

Loading...

Central trial contact

Yvon RUCH, MD; Saïd CHAYER, PhD, HDR

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems